CANCER INSIGHT Trademark

Trademark Overview


On Thursday, September 30, 2021, a trademark application was filed for CANCER INSIGHT with the United States Patent and Trademark Office. The USPTO has given the CANCER INSIGHT trademark a serial number of 97053419. The federal status of this trademark filing is REGISTERED as of Tuesday, December 27, 2022. This trademark is owned by Cancer Insight, LLC. The CANCER INSIGHT trademark is filed in the Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, Personal, and Legal & Social Services categories with the following description:

Providing independent review of clinical trials for business purposes; Business consulting and management in the field of clinical trials, namely, providing information management services; Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; Regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies; Providing business intelligence...

Regulatory compliance consulting in the field of medical products; Regulatory compliance consulting in the field of prescription drug sampling

Medical and scientific research, namely, conducting clinical trials for others; Conducting clinical trials for others; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals; Consulting services for others in the field of design, planning, and implementation project management of scientific research and clinical trials; Medical research; Scientific research and development; Biomedical research services; Providing information about medical and scientific research; Research and development of vaccines and medicines; Consulting services in the fields of biotechnology and pharmaceutical research and development; Pharmaceutical research and development; Pharmaceutical drug development services; Technical research in the field of pharmaceutical studies; Cond...
cancer insight

General Information


Serial Number97053419
Word MarkCANCER INSIGHT
Filing DateThursday, September 30, 2021
Status700 - REGISTERED
Status DateTuesday, December 27, 2022
Registration Number6933774
Registration DateTuesday, December 27, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 11, 2022

Trademark Statements


Goods and ServicesProviding independent review of clinical trials for business purposes; Business consulting and management in the field of clinical trials, namely, providing information management services; Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; Regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies; Providing business intelligence services in the fields of medical devices and pharmaceuticals
Goods and ServicesRegulatory compliance consulting in the field of medical products; Regulatory compliance consulting in the field of prescription drug sampling
Disclaimer with Predetermined Text"CANCER"
Goods and ServicesMedical and scientific research, namely, conducting clinical trials for others; Conducting clinical trials for others; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals; Consulting services for others in the field of design, planning, and implementation project management of scientific research and clinical trials; Medical research; Scientific research and development; Biomedical research services; Providing information about medical and scientific research; Research and development of vaccines and medicines; Consulting services in the fields of biotechnology and pharmaceutical research and development; Pharmaceutical research and development; Pharmaceutical drug development services; Technical research in the field of pharmaceutical studies; Conducting early evaluations in the field of new pharmaceuticals; Development of pharmaceutical preparations and medicines

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, October 28, 2021
Primary Code035
First Use Anywhere DateTuesday, December 31, 2013
First Use In Commerce DateTuesday, December 31, 2013

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 28, 2021
Primary Code042
First Use Anywhere DateTuesday, December 31, 2013
First Use In Commerce DateTuesday, December 31, 2013

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 28, 2021
Primary Code045
First Use Anywhere DateTuesday, December 31, 2013
First Use In Commerce DateTuesday, December 31, 2013

Trademark Owner History


Party NameCANCER INSIGHT, LLC D/B/A LUMABRIDGE
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressSAN ANTONIO, TX 78205

Party NameCancer Insight, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressSan Antonio, TX 78205

Party NameCancer Insight, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSan Antonio, TX 78205

Party NameCancer Insight, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSan Antonio, TX 78205

Trademark Events


Event DateEvent Description
Wednesday, March 8, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, December 27, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 27, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, October 11, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 11, 2022PUBLISHED FOR OPPOSITION
Wednesday, September 21, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, September 4, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 20, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 20, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 20, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 30, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 30, 2022NON-FINAL ACTION E-MAILED
Thursday, June 30, 2022NON-FINAL ACTION WRITTEN
Thursday, June 30, 2022ASSIGNED TO EXAMINER
Thursday, October 28, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 4, 2021NEW APPLICATION ENTERED